According to the missing-self hypothesis, natural killer (NK) cells survey for target cells that lack MHC-I molecules. The Ly49 receptor family recognizes loss of MHC-I and is critical for educating NK cells, conferring the ability to eliminate transformed or infected cells. In this study, we evaluated their requirement in innate immune surveillance of cancer cells using genetically manipulated mice with attenuated expression of Ly49 receptors (NKC KD ) in several models of carcinoma and metastasis. 
Introduction
Natural killer (NK) cells were originally identified by their unique killing of tumor cells without prior sensitization, which differed from the defined functions of T and B lymphocytes (1, 2) . Rare individuals with reduced NK cell numbers, cytotoxicity, and/or cytokine production are characteristically more susceptible to certain viral infections, highlighting the necessity of NK cells in immunity (3) . Low NK cell activity in cancer-diagnosed individuals is associated with poor prognosis, and those with advanced stage cancer often possess minimally cytotoxic NK cells (4) .
NK cells recognize tumor targets by the action of various activating and inhibitory receptors on their surface (5) . Members of the Ly49 receptor family, the murine functional homologue of the human killer-cell Ig-like receptor (KIR) family, can be either activating or inhibitory, and interact with MHC-I molecules (6) . NK cells detect aberrant cells with reduced surface expression of MHC-I through the Ly49 receptors: successful engagement of MHC-I transmits an inhibitory signal, whereas an absence of MHC-I and/or the presence of activating ligands induces killing (7) (8) (9) . Accordingly, target cells can express ligands that bind to a variety of activating and inhibitory receptors on NK cells, and the interplay between inhibitory and activating signals determines the NK cell response (5) . NK cell functionality depends on earlier exposure to MHC-I, as proposed by the education hypothesis, in which a self-specific Ly49 receptor must interact with self-MHC-I in order for the NK cell to become functional (10, 11) .
Cancer immunoediting describes how the immune system possesses a dual role in protecting the host, as well as in shaping the tumor environment (12) . Tumors evade immune recognition through various mechanisms, such as alteration of the tumor microenvironment or changes in MHC-I expression. Reduced or complete loss of MHC-I expression has been seen in a wide array of human cancers, including colorectal (13, 14) , breast (13, 15) , bladder (16) , ovarian (17) , and cervical carcinoma (18) , suggesting the presence of immunoediting.
Our laboratory has generated a mutant mouse strain in which expression levels of the Ly49 receptors-as well as the NKG2, CD94, and KLRI receptors-in the mouse natural killer gene complex (NKC) are downregulated (19) . NKC KD mice provide a genetically based approach to study the importance of Ly49 receptors in cancer immunosurveillance. As previously described (19) , NKC KD mice exhibit silenced Ly49 expression on approximately 80% of NK cells but with normal cell numbers and proportions, as well as unaffected expression levels of cell surface markers encoded outside the NKC. In this study, we show that Ly49 plays a major role in NK cell cancer immunosurveillance.
Materials and Methods

Mice
C57BL/6 (B6), B2m For experiments with poly(I:C) stimulation, 100 mg of poly(I:C) in PBS were injected intravenously 24 hours before tumor injection. Animals were euthanized 5 or 14 days following tumor inoculation and lungs were stained with X-gal (Bioshop) as described previously (22) . Representative tumor burden was determined on the largest lung (left) lobe, by the number of surface visible metastases. For histology, fresh-frozen lungs embedded in OCT were sectioned at 8 mm thickness and hematoxylin and eosin (H&E) stained.
Carcinogen-induced model
WT and NKC KD mice were injected subcutaneously into the hind flank with 100 mg methylcholanthrene dissolved in corn oil. Mice were monitored weekly for tumor development and scored as tumor positive upon tumor width exceeding 5 mm and exhibiting progressive growth. Tumor size was determined using an electronic caliper (Marathon) to measure length and width. Sarcoma growth rate (mm 2 / day) was calculated from tumor area with respect to number of days post-MCA injection.
Spontaneous lymphoma model
Em-myc Tg mice were monitored daily, and euthanized upon exhibiting progressively swollen lymph nodes upon palpation or respiratory distress. The spleen and lymph nodes were dissociated to attain a single cell suspension. Tumor cells were incubated with Fc block (anti-CD16/CD32), then stained with anti-IgM (eB121-15F9; eBioscience), anti-B220 (RA3-6B2; eBioscience), anti-H-2K b (AF6-88.5.5.3; eBioscience), anti-H-2D b (KH95; BD Biosciences), anti-Mult1 (5D10; eBioscience), and anti-pan Rae-1 (186107; R&D Systems). Mean fluorescence intensity (MFI) for H-2K b , H-2D b , Rae-1, and Mult1 expression in the spleen and lymph nodes of Em-myc Tg mice was standardized to levels in WT control mice.
In vitro and in vivo NK cell assays
Adherent lymphokine (IL2)-activated killer (ALAK) cells were grown in culture and used as effector cells in [
51 Cr]-release cytotoxicity assays, as previously described (23) . Intracellular staining for IFNg was performed as previously described (19) . NKp46
þ TCRb À cells were analyzed for IFNg by flow cytometry. Splenocyte and tumor cell rejection assays were performed as previously described (19, 21) . Alternatively, MHC-I-expressing, MHC-I-deficient, and MHC-I-deficient Rae-1b-expressing tumor cells were differentially labeled with 0.5, 3, and 8 mmol/L carboxyfluorescein diacetate succinimidyl ester (CFSE), and combined at a 1:1:1 ratio for a total of 2 Â 10 6 cells. Peritoneal cells were harvested 16 hours following injection and analyzed by flow cytometry for the presence of CFSElabeled tumor cells.
Statistical analysis
Statistical comparisons were performed on Kaplan-Meier plots depicting tumor onset using the log-rank test with Prism (GraphPad Software). For the remainder, statistical significance was determined by a two-tailed t test with cutoff P value of 0.05. Ã , P < 0.05; ÃÃ , P < 0.01; ÃÃÃ , P < 0.001; n.s., not significant.
Results
Accelerated tumor cell-induced flank tumor growth in NKC KD mice It was of interest to determine whether the lack of MHC-I immunosurveillance by NK cells in NKC KD mice affects longterm tumor control. Onset of MHC-I-deficient RMA-Sinduced flank tumor formation was detected at least 3 days earlier in NKC KD mice than WT mice ( Fig. 1A and C Accelerated melanoma cell-induced metastatic growth in NKC KD mice The B16F10.LacZ cells were also used in an experimental pulmonary metastases model to determine the ability of NKC KD mice to control metastatic growth. The number of metastases was greater in NKC KD mice compared with WT mice regardless of incubation time and cell dose ( Fig. 2A and  B) . Histologically, NKC KD mice exhibited increased metastatic nodules in the lung parenchyma, and loss of morpho-functional structures such as open and wide pulmonary alveoli, instead having alveoli obstructed with hyperemic areas (Fig.  2C ). Leukocyte infiltration can also be noted more frequently in NKC KD mouse lungs (Fig. 2C ). These data suggest an inability of NKC KD mice to eliminate B16F10.LacZ tumor cells before they are able to seed in the lungs.
To demonstrate that the observed hyporesponsiveness is not due to a cytotoxic defect, the NK cells in WT and NKC KD mice were directly activated by poly(I:C) injection. The lungs of untreated WT mice contained a mean of 45 metastases compared with a mean of 11 in the poly(I:C)-treated group (Fig. 2D) .
Comparatively, for NKC KD mice, metastases were also significantly reduced from a mean of 118 to 39 with poly(I:C) stimulation (Fig. 2D) . The efficacy of poly(I:C) treatment in both WT and NKC KD mice suggests that NK cells from NKC KD mice are still responsive if activated in a Ly49-independent manner.
Defective recognition of melanoma cell-induced experimental pulmonary metastases is MHC-I dependent To determine whether defective rejection of the parental, MHC-I-negative B16F10.LacZ lung metastases by NKC KD mice is due to defective missing-self recognition, the cells were stably transfected to express two MHC-I alleles, H-2K b and H-2D b , either individually or together (Fig. 3A) . Transfection of the cells did not affect expression of the NKG2D ligands, Rae-1 and Mult1 (Fig. 3B) . Expression of a single MHC-I allele was insufficient to significantly protect these tumors from WT NK control compared with the NKC KD ( Fig.  3C and E (Fig. 3D, F, and H (Fig. 4B) . Similar results were also seen with the experimental lung metastases, wherein the number of metastases was reduced in NKC KD -Ly49I Tg mice (mean of 24) compared with NKC KD (mean of 89; Fig. 4C ). These observed differences in the numbers of metastases suggest that Ly49I-mediated education is necessary to engender an NK cell response against tumors.
Accelerated onset and growth of MCA-induced sarcoma in NKC KD mice Previous studies show a role for NK cells in controlling methylcholanthrene (MCA)-induced tumors (26) (27) (28) . It was of interest to determine whether NKC KD mice with hyporesponsive NK cells would be more susceptible to MCA-induced tumors. NKC KD mice exhibited earlier sarcoma onset than WT; by day 85, all NKC KD mice had developed tumors, compared with approximately 50% of WT mice (Fig. 5A) . Tumor growth was accelerated in NKC KD mice (Fig. 5B) , with a significantly greater relative growth rate in NKC KD (mean of 1.97) than WT mice (mean of 0.65; Fig. 5C ). This suggests that control of MCA-induced tumors is impaired in NKC KD mice, and that the defect is not restricted to MHC-I-deficient tumor cell recognition.
Earlier onset of B-cell lymphoma and evidence for MHC-I-directed tumor immunoediting in NKC KD mice Em-myc transgenic mice possess the myc oncogene coupled to the immunoglobulin m enhancer, resulting in spontaneous B-cell lymphoma development, a lethal malignancy starting at 6 weeks of age (29) . Considering the pathologic importance of this cancer, especially with parallels to human Burkitt lymphoma, NKC KD .Em-myc Tg and WT.Em-myc Tg mice were generated to study the effect of silenced Ly49 expression. NKC KD mice developed lymphomas significantly earlier than WT mice, and exhibited reduced tumor control; following 100 days of age, approximately 60% of WT mice were lymphoma positive, compared with approximately 90% of NKC KD mice (Fig. 6A ). Although both groups possessed mice exhibiting delayed lymphoma onset, this lapse was more prominent in WT mice.
Because NKC KD mice lack MHC-I-educated NK cells, it was of interest to determine whether this would lead to cancer immunoediting. To test this hypothesis, immature (IgM contrast, expression of NKG2D ligands was negligible or very low, with no statistically significant differences between WT. Em-myc Tg and NKC KD .Em-myc Tg ( Supplementary Fig. S2A-S2G ). This highlights the significance of the observed downregulation of MHC-I in NKC KD .Em-myc Tg .
B lymphoma cells were isolated from a NKC KD .Em-myc Tg mouse that exhibited reduced MHC-I expression and low-level expression of NKG2D ligands (Fig. 6I ). This decrease in MHC-I expression rendered the tumor cells more susceptible to rejection by WT mice compared with NKC KD mice (Fig. 6J) . Furthermore, WT mice were able to better control the growth of B lymphoma cell-induced flank tumors (Fig. 6K) (Fig. 7B) . Similarly, in vivo rejection of RMA and RMA-S ectopically expressing Rae-1b by WT and NKC KD mice showed parallel results. Rejection of both Rae-1b high and Rae-1b low cells were similar ( Fig. 7C-E) , suggesting that NKG2D signaling is fully intact in NKC KD mice. Although rejection of RMA-S-Rae-1b was lower in NKC KD mice (Fig.  7F) , this is attributed to the MHC-I deficiency of these cells, and is evidenced by the differential rejection of RMA-S by WT and NKC KD mice. These results suggest that although NKC KD mice exhibit defective missing-self recognition, signaling through NKG2D, independent of MHC-I expression, is able to induce NK cell killing.
Decreased cytotoxicity but not IFNg production in NKC KD mice It was of interest to determine whether loss of Ly49 expression affects cytotoxicity or IFNg production by NK cells. NK cells from NKC KD mice exhibited normal production of IFNg following stimulation with PMAþionomycin ( Supplementary  Fig. S3A ), as well as various tumor cells: RMA, RMA-Rae-1b low , RMA-Rae-1b high , RMA-S, and RMA-S-Rae-1b ( Supplementary  Fig. S3B ), suggesting that loss of Ly49 does not affect IFNg production. A direct comparison of the killing between WT and NKC KD mice was studied through an in vitro cytotoxicity assay. The direct killing of the MHC-I-deficient tumor cells, RMA-S (Supplementary Fig. S3C ) and RMA-S-Rae-1b ( Supplementary  Fig. S3D ), by NKC KD -derived ALAK cells is impaired, while killing of MHC-I-expressing RMA and RMA-Rae-1b high and RMA-Rae-1b low is comparable between WT and NKC KD , suggesting a cytotoxicity defect with regards to missing-self recognition. Although there is observed killing of RMA-S by NKC KD cells, which is not expected, the levels are lower than that of WT and may be attributable to residual Ly49 expression on approximately 20% of NK cells in NKC KD mice. Overall, these results suggest that loss of Ly49 affects the cytotoxicity of the NK cells in response to missing-self signals. (26, 27) . Finally, in the oncogene-driven B-cell lymphoma model, we observed that mice on the NKC KD background develop lymphoma earlier than their WT counterparts also possessing the oncogene. The defect in NKC KD mice is due to reduced cytotoxicity of the NK cells because decreased killing is observed in response to missing-self. Signaling through NKG2D is fully intact in NKC KD mice; in vitro killing and in vivo rejection of RMA Rae-1-expressing target cells are similar between WT and NKC KD mice. The observed differential killing and rejection of RMA-S-Rae-1-expressing target cells by WT and NKC KD mice may be attributable to defective missing-self recognition in NKC KD mice; though there is evidence that signaling through NKG2D may compensate for such defects (19) .
Studies have reported that NK cells must undergo an education process in which interaction between inhibitory self-specific Ly49 and MHC-I molecules during development results in the acquisition of NK cell function (10, 11) . In our studies, following Ly49I Tg restoration in NKC KD mice, overall increased tumor control was observed, confirming that in vivo education is mediated by inhibitory self-specific Ly49. As well, the ability of Ly49I to rescue hyporesponsive NK cells supports that the phenomenon observed is the result of a loss of Ly49 expression and not due to the partial silencing of two other adjacent gene families, encoding the CD94/NKG2 and KLRI/E molecules (19) . Although flank tumor size in the NKC
KD -Ly49I
Tg mice is comparable with WT, suggesting near complete restoration of NK cell control, NKC KD -Ly49I Tg mice display slightly faster tumor growth and greater number of metastases, possibly due to the absence of other self-specific Ly49 receptors. In a 129-strain Ly49 repertoire, Ly49I binds to H-2K b , and Ly49V, G2, and O bind to H-2D b (31) , and so these three other Ly49 receptors may also be important for NK cell education. As well, the contribution of other non-self Ly49s remains unclear; there is evidence that Ly49A recognizes the nonclassical MHC-I molecule H2-M3 and mediates NK cell education (32, 33) . H2-M3-deficient mice exhibit defective cytotoxicity and tumor control (32, 33) .
MHC-I downregulation in various mouse and human cancers has been shown to be a common mechanism for tumor escape (34, 35 NK-mediated immunoediting has been reported in the context of the strong activating receptor NKG2D, with respect to expression of its ligands H60 and Rae-1 (36, 37) . Expression of H60a was reduced following passage in Rag2 À/À mice, which lack mature T and B lymphocytes, suggesting pressures from innate immune cells toward reduced ligand expression (36) . Increased expression of Rae-1 was observed in NKG2D-deficient mice with prostate adenocarcinoma but not in mice with B-cell lymphoma (37) , suggesting that different immune evasion mechanisms are undertaken by different cancers. In our analysis of B-cell lymphomas from NKC KD and WT mice, no difference in NKG2D ligand expression was observed, which further highlights the differential MHC-I expression seen between NKC KD .Em-myc Tg and WT.Em-myc Tg . Some cancers secrete NKG2D ligands as a way to nullify the function of NKG2D þ effector cells, and in such circumstances, MHC-I expression may be the determining factor in tumor clearance by NK cells (38) . Understanding the effects of MHC-I expression on clinical outcomes could help to improve current treatments using Ly49 and KIR receptor signaling (39, 40) . Low MHC-I expression is highly correlated with increased tumor-associated necrosis and poor prognosis (41, 42) ; however, complete loss of MHC-I expression is an indicator of good prognosis (43, 44) . Such observations suggest that total loss of MHC-I renders the tumor sensitive to NK cells. In contrast, partially reduced MHC-I allows them to potentially evade both NK and T cells: the allele for antigen presentation is lost thus eluding T-cell recognition, and the remaining allele can inhibit NK cells. Although cancer therapy clinical trials at present do not include tumor MHC-I expression analysis as part of treatment monitoring, such practice could potentially improve the success of current therapies with targeted regimens toward specific MHC-I level and allele alterations. This work contributes to a growing understanding of the role and importance of the Ly49 family in NK cells, not only as inhibitory receptors, but also as necessary mediators of NK cell function. This study provides in vivo support for the importance of Ly49 in NK cell-mediated tumor immunosurveillance and MHC-I-directed tumor immunoediting as a result of loss of Ly49 expression.
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